Literature DB >> 10442423

Irritable bowel syndrome in patients with Blastocystis hominis infection.

A Giacometti1, O Cirioni, A Fiorentini, M Fortuna, G Scalise.   

Abstract

The prevalence of Blastocystis hominis in stool specimens of individuals with gastrointestinal symptoms was evaluated to study a possible link between the protozoan and the irritable bowel syndrome. According to the Rome diagnostic criteria, 388 patients were evaluated. Altogether, 81 patients were classified as affected by irritable bowel syndrome. Blastocystis hominis was recovered from the stools of 38 subjects, 15 of whom belonged to the group with irritable bowel syndrome (P = 0.006). In addition, patients with irritable bowel syndrome were significantly more likely to have five or more Blastocystis hominis organisms per field (P = 0.031). In conclusion, there was a set of patients with irritable bowel syndrome in whom the presence of Blastocystis hominis may not be incidental.

Entities:  

Mesh:

Year:  1999        PMID: 10442423     DOI: 10.1007/s100960050314

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  31 in total

1.  Predominance of Blastocystis sp. subtype 4 in rural communities, Nepal.

Authors:  I L Lee; T C Tan; P C Tan; D R Nanthiney; M K Biraj; K M Surendra; K G Suresh
Journal:  Parasitol Res       Date:  2011-11-11       Impact factor: 2.289

2.  Blastocystis hominis infection in patient with regular dialysis.

Authors:  Miho Hayashi; Masahiko Inamori; Kouki Goto; Tomoyuki Akiyama; Kouji Fujita; Ikuko Ikeda; Toshio Fujisawa; Hirokazu Takahashi; Masato Yoneda; Kouji Hara; Yasunobu Abe; Hiroyuki Kirikoshi; Kensuke Kubota; Satoru Saito; Norio Ueno; Atsushi Nakajima; Yumiko Hamada; Hiroyuki Fukutomi; Hideyuki Satsuta
Journal:  J Gastroenterol       Date:  2006-06       Impact factor: 7.527

Review 3.  The role of Blastocystis sp. and Dientamoeba fragilis in irritable bowel syndrome: a systematic review and meta-analysis.

Authors:  Ali Rostami; Seyed Mohammad Riahi; Ali Haghighi; Vafa Saber; Bahram Armon; Seyyed Javad Seyyedtabaei
Journal:  Parasitol Res       Date:  2017-07-01       Impact factor: 2.289

4.  Postinfectious Irritable Bowel Syndrome.

Authors:  Kok-Ann Gwee
Journal:  Curr Treat Options Gastroenterol       Date:  2001-08

5.  Antiprotozoal potential of Salvadora persica against three virulent subtypes of Blastocystis sp.

Authors:  Mohammed A El-Bali; Abdulhafid Abdulhakim; Raafat T Mohamed; Mohamed A El-Malky; Rowaida A Bakri; Saeed A Al-Harthi
Journal:  J Parasit Dis       Date:  2020-07-27

6.  Molecular epidemiology of human Blastocystis isolates in France.

Authors:  Laetitia Souppart; Giovanna Sanciu; Amandine Cian; Ivan Wawrzyniak; Frederic Delbac; Monique Capron; Eduardo Dei-Cas; Kenneth Boorom; Laurence Delhaes; Eric Viscogliosi
Journal:  Parasitol Res       Date:  2009-03-17       Impact factor: 2.289

7.  Subtype analysis of Blastocystis isolates from symptomatic patients in Egypt.

Authors:  Laetitia Souppart; Hanaa Moussa; Amandine Cian; Giovanna Sanciu; Philippe Poirier; Hicham El Alaoui; Frederic Delbac; Kenneth Boorom; Laurence Delhaes; Eduardo Dei-Cas; Eric Viscogliosi
Journal:  Parasitol Res       Date:  2009-12-02       Impact factor: 2.289

Review 8.  New insights on classification, identification, and clinical relevance of Blastocystis spp.

Authors:  Kevin S W Tan
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

9.  Blastocystis hominis as a cause of hypoalbuminemia and anasarca.

Authors:  E Nassir; J Awad; A B Abel; J Khoury; M Shay; F Lejbkowicz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-04-27       Impact factor: 3.267

10.  Oh my aching gut: irritable bowel syndrome, Blastocystis, and asymptomatic infection.

Authors:  Kenneth F Boorom; Huw Smith; Laila Nimri; Eric Viscogliosi; Gregory Spanakos; Unaiza Parkar; Lan-Hua Li; Xiao-Nong Zhou; Ulgen Z Ok; Saovanee Leelayoova; Morris S Jones
Journal:  Parasit Vectors       Date:  2008-10-21       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.